ArticlePituitary2026

Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort.

Kevin C J Yuen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.